Relationship Graph Explorer
Follow the connections
Every herb, ingredient, formula, gene target, and disease — connected through real research. Search, pick a subject, and navigate the graph in any direction.
🌿
Herb
6,826
→
⚗️
Ingredient
44,595
→
🧬
Gene Target
15,505
→
🏥
Disease
30,170
→
🧪
Evidence
23,295
trials · metas · refs
Plus 6,743 TCM formulas connecting herbs together
⚗️ Ingredient
Bile acid
2
Clinical Trials
13
Meta-Analyses
0
PubMed References
Top Conditions Studied with Bile acid
The Cochrane Hepato-Biliary Group 2
Type 2 diabetes mellitus (T2DM) is a severe metabolic diseas 1
PI3K Gene Mutation|AKT Gene Mutation|MTOR Gene Mutation|Canc 1
Type 2 diabetes 1
Obesity|Healthy 1
The Cochrane Metabolic and Endocrine Disorders Group 1
Obesity is a growing global issue and diet plays an inevitab 1
Nonalcoholic fatty liver disease has become the most common 1
Liver cirrhosis is the end stage liver disease resulting fro 1
Intrahepatic cholestasis of pregnancy is a gestation-specifi 1
Intrahepatic cholestasis of pregnancy (ICP) is a multifactor 1
Intrahepatic cholestasis of pregnancy (also known as obstetr 1
📋 Sample Trials
NCT05314374
Effect of Bile Acids on Satiety, Cell Function and Body Weight in Patients With Obesity and Abnormal Satiety Phenotype
Enrolling_By_Invitation · Phase 1
NCT05571670
Bile Acids in Acute Insulin Resistance
Recruiting
📊 Sample Meta-Analyses
CRD42012001911
A systematic review and economic evaluation of SeHCAT (Tauroselcholic [75Selenium] acid) for the investigation of bile acid malabsorption (BAM) and measurement of bile acid pool loss
CRD42012002552
Effect of bile acid sequestrants on glycaemic control: a systematic review and meta-analysis of randomised controlled trials
Type 2 diabetes mellitus (T2DM) is a severe metabolic disease characterised by r
CRD42015032326
Bile acid sequestrants in inflammatory bowel disease
Inflammatory bowel disease
📚 Sample References
None linked yet.
⚗️ All Ingredient data fields for Bile acid
⚗️ Identity
Name
Bile acid
Aliases / Synonyms
Bile salt; CHEBI:22868; Gallensaeure; Gallensaeuren; 5beta-bile acid; 5beta-bile acids; Acid, Bile; CHEBI:3098; CHEBI:138366
🧪 Chemistry
Molecular Weight
408.5790
LogP
3.4487
Drug-likeness
0.571
H-Bond Acceptors
4
H-Bond Donors
4
Rotatable Bonds
4
🔬 Structures
Canonical SMILES
CC(CCC(=O)O)C1CCC2C1(C(CC3C2C(CC4C3(CCC(C4)O)C)O)O)C
Isomeric SMILES
CC(CCC(=O)O)C1CCC2C1([C@H](CC3C2[C@@H](C[C@H]4C3(CC[C@H](C4)O)C)O)O)C
InChIKey
BHQCQFFYRZLCQQ-UMZBRFQRSA-N
InChI
InChI=1S/C24H40O5/c1-13(4-7-21(28)29)16-5-6-17-22-18(12-20(27)24(16,17)3)23(2)9-8-15(25)10-14(23)11-19(22)26/h13-20,22,25-27H,4-12H2,1-3H3,(H,28,29)/t13?,14-,15+,16?,17?,18?,19+,20-,22?,23?,24?/m0/s1
🔗 External References
🔍 Raw view — every non-empty column on this row (27 fields)
name
Bile acid
common names
Bile salt; CHEBI:22868; Gallensaeure; Gallensaeuren; 5beta-bile acid; 5beta-bile acids; Acid, Bile; CHEBI:3098; CHEBI:138366
herb ingredient id
HBIN018507
canonical smiles
CC(CCC(=O)O)C1CCC2C1(C(CC3C2C(CC4C3(CCC(C4)O)C)O)O)C
isomeric smiles
CC(CCC(=O)O)C1CCC2C1([C@H](CC3C2[C@@H](C[C@H]4C3(CC[C@H](C4)O)C)O)O)C
inchi
InChI=1S/C24H40O5/c1-13(4-7-21(28)29)16-5-6-17-22-18(12-20(27)24(16,17)3)23(2)9-8-15(25)10-14(23)11-19(22)26/h13-20,22,25-27H,4-12H2,1-3H3,(H,28,29)/t13?,14-,15+,16?,17?,18?,19+,20-,22?,23?,24?/m0/s1
inchikey
BHQCQFFYRZLCQQ-UMZBRFQRSA-N
mol wt
408.5790
num h acceptors
4
num h donors
4
mol logp
3.4487
num rotatable bonds
4
drug likeness
0.571
tcmid ingredient id
23866
pubchem cid
439520
📋 Clinical Trials
2 · subject of clinical studyNCT05314374 Effect of Bile Acids on Satiety, Cell Function and Body Weight in Patients With
→ Obesity|Healthy
NCT05571670 Bile Acids in Acute Insulin Resistance
→ PI3K Gene Mutation|AKT Gene Mutation|MTOR Gene Mut
📊 Meta-Analyses
12 · systematic reviewCRD42012001911 A systematic review and economic evaluation of SeHCAT (Tauroselcholic [75Seleniu
CRD42012002552 Effect of bile acid sequestrants on glycaemic control: a systematic review and m
→ Type 2 diabetes mellitus (T2DM) is a severe metabo
CRD42015032326 Bile acid sequestrants in inflammatory bowel disease
→ Inflammatory bowel disease
CRD42016045492 Bile acid derivatives for people with primary sclerosing cholangitis [Cochrane P
→ The Cochrane Hepato-Biliary Group
CRD42016045493 Bile acid derivatives for people with primary biliary cholangitis [Cochrane Prot
→ The Cochrane Hepato-Biliary Group
CRD42016045966 Adjunctive bile acid sequestrant therapy for hyperthyroidism in adults [Cochrane
→ The Cochrane Metabolic and Endocrine Disorders Gro
CRD42017056590 Total serum bile acids or serum bile acid profile, or both, for the diagnosis of
→ Intrahepatic cholestasis of pregnancy (also known
CRD42017083002 Total serum bile acids or serum bile acid profile, or both, for the diagnosis of
→ Intrahepatic cholestasis of pregnancy is a gestati
CRD42018111642 Obstetric outcomes as assessed by bile acid levels associated with intrahepatic
→ Intrahepatic cholestasis of pregnancy (ICP) is a m
CRD42018115768 Targeting bile acid metabolism in obesity reduction: a systematic review and met
→ Obesity is a growing global issue and diet plays a
CRD42021238193 Predictive value of liver cirrhosis using metabolite biomarkers of bile acid in
→ Liver cirrhosis is the end stage liver disease res
CRD42022345481 Correlation between serum bile acid and nonalcoholic fatty liver disease: A Syst
→ Nonalcoholic fatty liver disease has become the mo
How relationships are computed
- Clinical Trials / Meta-Analyses / References: direct foreign-key link via
subject_entity_id(Phase 2d wireup) - Formula ↔ Herbs: text bridge via
formulas.herbs_in_pinyinmatchingherbs.pinyin_name - Herb ↔ Ingredient:
empty — needs
HERB_herb_ingredientimport - Ingredient ↔ Target:
empty — needs
HERB_ingredient_targetimport - Target ↔ Disease:
empty — needs
HERB_target_diseaseimport - Herb → Target → Disease (full chemical spine): awaiting Phase 2e link tables